Citadel Advisors’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,114
Closed -$108K 13953
2022
Q2
$108K Sell
21,114
-22,047
-51% -$113K ﹤0.01% 11340
2022
Q1
$284K Sell
43,161
-4,088
-9% -$44.8K ﹤0.01% 10722
2021
Q4
$865K Buy
+47,249
New +$1.57M ﹤0.01% 8307
2021
Q3
Sell
-5,082
Closed -$307K 14946
2021
Q2
$307K Sell
5,082
-8,872
-64% -$548K ﹤0.01% 11203
2021
Q1
$898K Sell
13,954
-1,065
-7% -$73.1K ﹤0.01% 8382
2020
Q4
$631K Buy
15,019
+9,658
+180% +$350K ﹤0.01% 7715
2020
Q3
$192K Sell
5,361
-59,355
-92% -$2.28M ﹤0.01% 8841
2020
Q2
$2.34M Buy
+64,716
New +$2.62M ﹤0.01% 4297

Other funds holding GTH

Citadel Advisors's GTH Position: Q3 2022 in Review

Citadel Advisors sold out of Genetron Holdings Limited ADS (GTH) in Q3 2022, closing a stake of 21,114 shares — an estimated $108K sold.

Citadel Advisors first reported a position in GTH in Q2 2020 and held it in 8 quarters. The position peaked at $2.34M in Q2 2020. 25 funds tracked by Wall St. Rank hold GTH as of Q3 2022.

  • Citadel Advisors reported no remaining Genetron Holdings Limited ADS position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 21,114 Genetron Holdings Limited ADS shares in Q3 2022, an estimated $108K.
  • Citadel Advisors first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 8 quarters.
  • Citadel Advisors's Genetron Holdings Limited ADS position peaked at $2.34M in Q2 2020.
  • 25 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.